Dare Bioscience
dare phosphate vaginal gel gel for bacterial approved for the treatment of bacterial the most common vaginal condition in women of reproductive age one time intravaginal administration commercialization collaborator approved fast track and priority review designations i organon | Dare Bioscience
Company
Deck Type
Sector
Industry
Deck date
February 2023
Slide
16 of 54
Similar slides by Dare Bioscience
See diffirences between slides (animation)
Investor Presentation
October 2022
approved for the treatment of bacterial the most common vaginal condition in women of reproductive age one time intravaginal administration approved fast track and priority review designations phosphate vaginal gel | Dare Bioscience
Other recent decks by Dare Bioscience
See all presentations (5 decks)
Results
November 2023
Investor Presentation
August 2023
Investor Presentation
July 2023
Investor Presentation
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io